Table 3. Reliability of HES data; Internal reliability: Intra-class correlation coefficient for each comorbidity; external reliability: Proportion of agreement for the diagnosis of the index cancer between the diagnostic fields of HES and the cancer registration data, by cancer and year of diagnosis.
Larynx (2013)* | Larynx** | |||||
---|---|---|---|---|---|---|
95% CI | 95% CI | |||||
Internal reliability | ICC | low | high | ICC | low | high |
Myocardial infarction | 0.27 | 0.17 | 0.37 | 0.27 | 0.24 | 0.30 |
Congestive heart failure | 0.33 | 0.21 | 0.44 | 0.39 | 0.35 | 0.44 |
Peripheral vascular disease | 0.26 | 0.16 | 0.35 | 0.34 | 0.31 | 0.38 |
Cerebrovascular disease | 0.29 | 0.20 | 0.38 | 0.33 | 0.30 | 0.36 |
Dementia | 0.56 | 0.32 | 0.80 | 0.62 | 0.53 | 0.72 |
Chronic pulmonary disease | 0.38 | 0.31 | 0.45 | 0.54 | 0.52 | 0.56 |
Rheumatic disease | 0.30 | 0.11 | 0.50 | 0.50 | 0.42 | 0.57 |
Peptic ulcer disease | 0.09 | 0.01 | 0.18 | 0.19 | 0.15 | 0.22 |
Mild liver disease | 0.31 | 0.20 | 0.43 | 0.39 | 0.34 | 0.44 |
Diabetes without chronic complication | 0.38 | 0.28 | 0.48 | 0.52 | 0.48 | 0.56 |
Diabetes with chronic complication | 0.18 | -0.06 | 0.41 | 0.42 | 0.31 | 0.53 |
Hemiplegia or paraplegia | 0.29 | 0.12 | 0.46 | 0.34 | 0.27 | 0.42 |
Renal disease | 0.19 | 0.07 | 0.31 | 0.49 | 0.44 | 0.54 |
Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin | 0.29 | 0.01 | 0.58 | 0.35 | 0.27 | 0.43 |
Moderate or severe liver disease | 0.31 | 0.10 | 0.53 | 0.28 | 0.20 | 0.36 |
Metastatic solid tumor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
AIDS/HIV | 0.25 | -0.88 | 1.39 | 0.43 | -0.10 | 0.96 |
Morbid obesity | 0.18 | 0.06 | 0.31 | 0.30 | 0.24 | 0.36 |
External reliability | ||||||
Proportion agreement HES/ONS | 86.31 | 84.62 | 87.87 | 86.26 | 85.72 | 86.79 |
*Larynx 2013-cohort, N = 1,789
** All cohorts, N = 16,112